Current Interview: Todd Hobbs

Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from ADA 2017.

Dr. Todd Hobbs is Vice President and Chief Medical Officer for Novo Nordisk in North America, where he leads the organization’s focus on the implications of diabetes for the patient, healthcare system, and healthcare professionals. He provides overall medical guidance to Novo Nordisk’s diabetes and obesity-related projects. Prior to working at Novo Nordisk, Dr. Hobbs had established a clinical practice based in Louisville, Kentucky, focusing on the intensive management of patients with diabetes of all ages, and served as chairman of the medicine department for a large regional medical center in Kentucky. During this 10year clinical career, he cared for more than 2,500 adults and children with diabetes, including outpatient and inpatient care, as well as intensive care.

Featured videos include:

Pt.1: Background and Introduction

Pt.2: Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine

Pt.3: Dual 7 Trial- Xultophy

Pt.4: GLP-1 Drug Trials

Pt.5: The Future of Novo Nordisk

or view the complete interview with Todd Hobbs here: Complete Interview.

Click here to read a transcript of this interview.